Literature DB >> 12672580

Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces.

Yoon-Jong Lee1, Won-Kyu Yu, Tae-Ryeon Heo.   

Abstract

The antimicrobial activity against Clostridium difficile of 109 lactic acid bacteria (LAB) isolated from 32 healthy Korean infants was measured. The ability to show similar activity against Escherichia coli O157:H7 and Staphylococcus aureus was also looked for. Twelve of the 109 LAB showed activity against C. difficile and 19 strains were active against E. coli O157:H7, but none against S. aureus. Four strains had antimicrobial activity against both C. difficile and E. coli O157:H7. Of the 12 strains that had activity against C. difficile, four strains were excluded as Streptococcus species, while the other eight were identified using polymerase chain reaction (PCR) assays using group-specific primers designed from the nucleotide sequences of the 16S rDNA and internal transcribed spacer (ITS) regions of the Bifidobacterium and Lactobacillus species. Based on the sequencing results, the eight strains screened were identified as Bifidobacterium infantis and Lactobacillus salivarius.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672580     DOI: 10.1016/s0924-8579(02)00389-8

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  11 in total

1.  Assessing inhibitory activity of probiotic culture supernatants against Pseudomonas aeruginosa: a comparative methodology between agar diffusion, broth culture and microcalorimetry.

Authors:  Mansa Fredua-Agyeman; Simon Gaisford
Journal:  World J Microbiol Biotechnol       Date:  2019-03-06       Impact factor: 3.312

2.  Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

Authors:  Dermot P B McGovern; Michelle R Jones; Kent D Taylor; Kristin Marciante; Xiaofei Yan; Marla Dubinsky; Andy Ippoliti; Eric Vasiliauskas; Dror Berel; Carrie Derkowski; Deb Dutridge; Phil Fleshner; David Q Shih; Gil Melmed; Emebet Mengesha; Lily King; Sheila Pressman; Talin Haritunians; Xiuqing Guo; Stephan R Targan; Jerome I Rotter
Journal:  Hum Mol Genet       Date:  2010-06-22       Impact factor: 6.150

3.  Molecular microbial analysis of lactobacillus strains isolated from the gut of calves for potential probiotic use.

Authors:  Lorena P Soto; Laureano S Frizzo; Ezequiel Bertozzi; Elizabeth Avataneo; Gabriel J Sequeira; Marcelo R Rosmini
Journal:  Vet Med Int       Date:  2009-09-01

4.  Competitive inhibition of adherence of enterotoxigenic Escherichia coli, enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027.

Authors:  Shi-Shun Zhong; Zhen-Shu Zhang; Ji-De Wang; Zhuo-Sheng Lai; Qun-Ying Wang; Ling-Jia Pan; Yue-Xin Ren
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

5.  Comparison of antagonistic ability against enteropathogens by G+ and G- anaerobic dominant components of human fecal microbiota.

Authors:  D A Gomes; A M L Souza; R V Lopes; A C Nunes; J R Nicoli
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

6.  At-hatch administration of probiotic to chickens can introduce beneficial changes in gut microbiota.

Authors:  Stephen Baldwin; Robert J Hughes; Thi Thu Hao Van; Robert J Moore; Dragana Stanley
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

7.  Selective growth inhibitory effect of biochanin A against intestinal tract colonizing bacteria.

Authors:  Olga Sklenickova; Jaroslav Flesar; Ladislav Kokoska; Eva Vlkova; Katerina Halamova; Jan Malik
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

8.  Antagonistic Characteristics Against Food-borne Pathogenic Bacteria of Lactic Acid Bacteria and Bifidobacteria Isolated from Feces of Healthy Thai Infants.

Authors:  Supansa Uraipan; Tipparat Hongpattarakere
Journal:  Jundishapur J Microbiol       Date:  2015-06-01       Impact factor: 0.747

9.  Bifidobacteriumlongum subsp. infantis CECT7210 (B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens.

Authors:  Lorena Ruiz; Ana Belén Flórez; Borja Sánchez; José Antonio Moreno-Muñoz; Maria Rodriguez-Palmero; Jesús Jiménez; Clara G de Los Reyes Gavilán; Miguel Gueimonde; Patricia Ruas-Madiedo; Abelardo Margolles
Journal:  Nutrients       Date:  2020-10-24       Impact factor: 5.717

10.  Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria.

Authors:  Winschau F van Zyl; Shelly M Deane; Leon M T Dicks
Journal:  Gut Microbes       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.